fbpx

Day: August 15, 2019

What happened to the right to choose your healthcare?

From atop the lecterns at the Democratic presidential debates and the White House, a common trope is dismantling and rejiggering how healthcare is delivered in America.

For the left, the emphasis is on expanding who can access government-backed health insurance programs while cutting off the role of the private sector. On the right, President Trump is looking to import drugs and pharmaceutical price controls from abroad.

Missing in both of these visions is the essential component that governs every other sector of the economy: the freedom to choose.

Much like housing, transportation, and education, it’s clear that the entire healthcare sector needs disruption.

We need out-of-the-box thinking, innovation, and on-demand delivery that will bring costs down for ordinary people. It’s this formula that has empowered millions to rise out of poverty, make a decent living for their families, and expand consumer choice to makes their lives better.

But both the Democrats and Trump are leading Americans astray on what really matters when it comes to healthcare.

Sens. Bernie Sanders, Elizabeth Warren, Cory Booker, and Kamala Harris have serious proposals to totally ban the private healthcare market in favor of a “Medicare For All” system. That means every American would be thrown into the government insurance program reserved for our seniors.

All administration, billing, reimbursement claims, and hospital contracts for over 350 million people would be handled by the federal government. For a country as unique, diverse, and large as the United States, this just couldn’t be carried out effectively. The CBO’s analysis of a single-payer system admits that new taxes and an entirely new administrative bureaucracy would take years to implement.

Such plans would make it illegal for Americans to choose the type of healthcare coverage that fit them best, depriving them of fundamental choices.

This makes two grandiose and flawed assumptions. One, that a top-down government reorganization of insurance and health services would be the best method to deliver healthcare, and two, that the individual consumer cannot be trusted to make decisions about their care. That is wrong.

People choose different healthcare plans depending on their employment situation, their age, or their lifestyle.

Many younger working people, such as myself, don’t have comprehensive insurance because it doesn’t make economic sense. We’d rather pay out of pocket for small expenses and use high-deductible disaster insurance when necessary. The young and healthy tend to shy away from the large insurance plans for these very reasons.

For the 8.8 percent of Americans without health insurance, would they benefit from a mass reorganization of the system that would offer the care reserved for our seniors if the cost comes in the form of higher taxes and less consumer choice?

The same applies to Trump’s well-intended but flawed plans on importing drugs from single-payer systems around the world.

The reason pharmaceutical drugs are more expensive has more to do with subsidies than cost. Most drugs are born from innovative American firms but are subsidized greatly or negotiated for lower rates by governments who import them. Firms can afford this because it’s offset by American prices, meaning the rest of the world is freeriding on American innovation and intellectual property.

They achieve this by reducing access and choice. It’s no secret that the lion’s share of pharmaceutical drugs are available in the U.S. while they’re unavailable in the countries that refuse to pay for them. So yes, the prices of drugs may be cheaper in Canada or Norway, but the supply and choices are lacking. Do we want fewer choices of drugs for lower costs or more choices and prices at market rate?

What matters most when it comes to our personal health is the freedom to choose. Whether that it’s our doctor, insurance program, or drugs we buy, Americans want to be able to pick what works best from them. Grandiose plans that seek to completely reorganize how many taxes we pay and how we receive care would severely restrict that.

That may be a well-intended path, but one that millions of Americans are right to reject.  

Yaël Ossowski is deputy director of the Consumer Choice Center

Published in the Chicago Tribune: https://www.chicagotribune.com/lifestyles/health/sns-tns-bc-healthcare2-commentary-20190815-story.html

Published in Globe Gazette: https://globegazette.com/opinion/columnists/commentary-what-happened-to-the-right-to-choose-your-health/article_b941a988-7864-51e5-98e2-5e987626ce16.html?utm_source=dlvr.it&utm_medium=twitter

Published in Duluth News Tribune: https://www.duluthnewstribune.com/opinion/columns/4636779-National-View-Column-Americans-deserve-the-right-to-choose-their-health-care

Canadians support paying blood plasma donors – survey

A majority of Canadians support paying people for donations of plasma, which are blood products used to make specialized medicines, a new poll has found.

Sixty-three per cent of Canadians endorse the idea as “morally appropriate” while support is strongest, at 75 per cent, among those between the ages of 18-34.

But a narrow majority of older Canadians, age 55 and up, believe paying people for plasma donations is “morally inappropriate”.

The donation of plasma is similar to blood donations, but the process takes longer, about two hours instead of 30 minutes.

Because of a lack of plasma supply in Canada, about 75 per cent of it used in this country comes from the U.S., where donors are paid.

Last week, Canadian Blood Services announced plans to open three plasma-only donation centres, including one in Kelowna scheduled to open in the spring of 2021, to try bolster the country’s supply.

The B.C. NDP government banned paid plasma in 2018, and similar bans exist in Alberta and Ontario.

The new survey, commissioned by the Consumer Choice Centre, found that 56 per cent of B.C. residents support paying plasma donors as “morally appropriate. Although a majority, that was the lowest level of support found in Canada’s six main regions.

Supporters of a ban on paying people for plasma donations say it may negatively affect blood donations, exploits the poor, and violates human dignity because blood should not be paid for.

Those who support payment for plasma donations say the process is safe, with no transmission of any diseases from paid-for plasma donors in the past 20 years, and it would address Canada’s plasma shortage.

Plasma, a yellow liquid that houses red and white blood cells, is increasingly used to make a variety of medicines for the treatment of conditions and illnesses such as burns, respiratory diseases, and immune deficiencies.

The usage of one plasma protein product, immune globulin, has doubled internationally over the past decade.

David Clement, Toronto-based representative of the Consumer Choice Centre, said in a release the results of the new opinion poll should convince governments the public supports payment for plasma donations.

“We have long argued that allowing compensation for blood plasma donors was overdue, and now we know that Canadians from coast to coast agree,” Clement said in a release.

In Saskatchewan and New Brunswick, where paid plasma clinics operate, donors are typically paid between $30-$50.

Donors must go through medical screening to ensure they’re healthy. Their plasma is subject to the same kind of analysis and treatment as other donated blood products to ensure it’s safe to use.

Read more here

Scroll to top
en_USEN